Keski-Nisula L, Kirkinen P, Katila M L, Ollikainen M, Suonio S, Saarikoski S
Department of Obstetrics and Gynecology, Kuopio University Hospital, Finland.
Am J Perinatol. 1997 Mar;14(3):151-6. doi: 10.1055/s-2007-994117.
The aim of this study was to examine the relationship between maternal peripartal infectious morbidity and amniotic fluid colonization by U. urealyticum. Amniotic fluid specimens for bacterial and mycoplasmal cultures were obtained by aspiration at nonelective cesarean section from 98 pregnant women. Amniotic fluid cultures revealed micro-organisms in 70 (71%) parturients and U. urealyticum was the most frequently isolated species, detected in the specimens from 38 (39%) women. In the total study population, the prevalence of clinically defined infectious morbidity was 26%, including 8 (8%) patients with chorioamnionitis, 11 (11%) with endometritis, 5 (5%) with urinary tract infection, and 4 (4%) with wound infection. A significant association between the amniotic fluid U. urealyticum colonization and increased maternal peripartal infectious morbidity was observed (p < 0.0027; relative risk 4.1; 95% confidence limits 1.6 to 10.7). Amniotic fluids positive for U. urealyticum were significantly more often positive for other potentially pathogenic bacteria (p < 0.0024) and particularly for Bacteroides spp. (p < 0.0074). Our results support the existence of an association between amniotic fluid U. urealyticum invasion and maternal infectious morbidity. However, U. urealyticum was not usually isolated alone from amniotic fluids but combined with other pathogenic bacteria, the severity of infections were not enhanced when U. urealyticum was present and parturients with diagnosed infections managed well without specific antibiotic against U. urealyticum. Hence, it appears that the significance of U. urealyticum in maternal infections in this study population was mainly based on its interactions with other bacteria.
本研究旨在探讨孕产妇围产期感染性疾病与解脲脲原体羊水定植之间的关系。通过非选择性剖宫产从98名孕妇中抽取羊水标本进行细菌和支原体培养。羊水培养显示,70名(71%)产妇的标本中有微生物生长,解脲脲原体是最常分离出的菌种,在38名(39%)女性的标本中检测到。在整个研究人群中,临床定义的感染性疾病患病率为26%,包括8名(8%)绒毛膜羊膜炎患者、11名(11%)子宫内膜炎患者、5名(5%)尿路感染患者和4名(4%)伤口感染患者。观察到羊水解脲脲原体定植与孕产妇围产期感染性疾病增加之间存在显著关联(p < 0.0027;相对风险4.1;95%置信区间1.6至10.7)。解脲脲原体阳性的羊水标本中,其他潜在致病菌阳性的频率明显更高(p < 0.0024),尤其是拟杆菌属(p < 0.0074)。我们的结果支持羊水解脲脲原体侵袭与孕产妇感染性疾病之间存在关联。然而,解脲脲原体通常并非单独从羊水中分离出来,而是与其他病原菌共存,解脲脲原体存在时感染的严重程度并未增强,且诊断为感染的产妇在未使用针对解脲脲原体的特异性抗生素的情况下治疗效果良好。因此,在本研究人群中,解脲脲原体在孕产妇感染中的意义似乎主要基于其与其他细菌的相互作用。